Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin g (igg) and iga antibodies in serum and mucosal secretions after nasal immunization. J Virol, 76(2): 517–524.īurns J W, Siadat-Pajouh M, Krishnaney A A, et al. Protective effect of rotavirus vp6-specific iga monoclonal antibodies that lack neutralizing activity. Modified polyriboinosinic-polyribocytidylic acid complex: Sustained interferonemia and its physiological associates in humans. Infect Immun, 25(3): 831–837.Ĭzerkinsky C, Anjuere F, Mcghee J R, et al. Mucosal immunity and tolerance: Relevance to vaccine development.
Immunol Rev, 170: 197–222.įouchier R A, Kuiken T, Schutten M, et al. Aetiology: Koch’s postulates fulfilled for sars virus.
Effects of different immunization protocols and adjuvant on antibody responses to inactivated sars-cov vaccine. Immunologic-mediated protection of trypanosoma congolense-infected mice by polyribonucleotides. Synthetic double-stranded rna poly(i:C) combined with mucosal vaccine protects against influenza virus infection. When two strands are better than one: The mediators and modulators of the cellular responses to double-stranded rna. Enhancement of mucosal immunization with virus-like particles of simian immunodeficiency virus. Kapikian A Z, Hoshino Y, Chanock R M, et al.
Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children. Koutsky L A, Ault K A, Wheeler C M, et al.
#HALOMD DOWNLOAD TRIAL#
#Pika mouse trialĪ controlled trial of a human papillomavirus type 16 vaccine. Antisense rna: Function and fate of duplex rna in cells of higher eukaryotes. Interaction of antigens and antibodies at mucosal surfaces. A tlr3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic.
0 kommentar(er)
